Clinical Trials Logo

Sleep Deprivation clinical trials

View clinical trials related to Sleep Deprivation.

Filter by:

NCT ID: NCT01989741 Completed - Sleep Deprivation Clinical Trials

Effect of Sleep Restriction on Decision Making and Inflammation

Start date: September 2012
Phase: N/A
Study type: Interventional

- hypothesis: sleep restriction in healthy subject trigger alteration of decision making associated with immuno-inflammatory changes - inclusion criterias: healthy subjects, men, under 35 years, BMI<26, no sleep troubles, intermediate chronotype - design: 12 subjects, longitudinal study 2 days of baseline, 7 night of sleep restriction (4h sleep/night), recovery (1, 2, 3 and 9 normal sleep nights). - parameters: decision making tests, reaction time, wakefulness test, biological parameters (cathecholamines, pro-inflammatory cytokines...), heart rate, blood pressure - control of sleep restriction: continuous polysomnographic survey

NCT ID: NCT01966315 Terminated - Delirium Clinical Trials

The Comparison of Dexmedetomidine and Midazolam for the Sleep in Intensive Care Unit

Start date: October 2013
Phase:
Study type: Observational

The investigators are going to compare the sleep quality and quantity between dexmedetomidine group and midazolam group using 24 hour polysomnography in critically ill patients. And the investigators also compare the incidence of delirium between the two groups.

NCT ID: NCT01930279 Not yet recruiting - Sleep Deprivation Clinical Trials

Effect of Partial Sleep Deprivation on Immunological System in Peripheral Blood

Start date: September 2013
Phase: N/A
Study type: Observational

Sleep deprivation was found to affect many organs including the immune system and predisposing for various health consequences including diabetes hypertension infections and increase in neoplastic diseases. Subjects will be evaluated for immune parameters in peripheral blood test following a regular nigh sleep and compared with a test performed following a night shift in which they slept less than 3 hours. Each participant will serve as its own control.

NCT ID: NCT01920334 Recruiting - Clinical trials for Acute Coronary Syndrome

Effects of Zolpidem CR® in Sleep and Heart Recovery in Cardiac Intensive Care Unit Patients

Start date: July 2013
Phase: Phase 4
Study type: Interventional

A double blind, randomized, placebo-controlled study will be conducted in cardiac ICU patients who had been diagnosed with acute coronary syndrome, using a sleep promoting drug (zolpidem controlled release). The study hypothesis is that sleeping better can improve the heart recovery in patients with a diagnosis of acute coronary syndrome.

NCT ID: NCT01828320 Completed - Eveningness/Sleep Clinical Trials

Triple Vulnerability? Circadian Tendency, Sleep Deprivation and Adolescence

Start date: March 2013
Phase: N/A
Study type: Interventional

There is an urgent need to identify modifiable mechanisms contributing to risk and vulnerability among youth. The investigators test the hypothesis that eveningness, the tendency to go to sleep late and wake late, is an important contributor to, and even cause of, vicious cycles that escalate vulnerability and risk among youth. This study seeks to determine whether two interventions to reduce eveningness can reduce risk and confer resilience in critical aspects of health, development and functioning in youth.

NCT ID: NCT01823263 Recruiting - Sleep Clinical Trials

Metabolic and Cognitive Parameters Following Partial Sleep Deprivation

Start date: April 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether partial sleep deprivation, as compared with normal sleep, influences certain metabolic and cognitive parameters, related to food intake, hunger and memory functions, when participants are shielded from external time cues.

NCT ID: NCT01800253 Completed - Sleep Clinical Trials

The Effects of Acute Total Sleep Deprivation Versus Normal Sleep on Metabolism

Start date: March 2013
Phase: N/A
Study type: Interventional

The study proposes to investigate whether acute total deprivation affects metabolism as measured through blood and peripheral tissues. Its aim is also to investigate how acute total sleep deprivation affects neurodegenerative markers, as well as hormones, memory performance and aspects of appetite regulation.

NCT ID: NCT01794689 Completed - Pain Clinical Trials

Mechanisms of Sleep Disruption Hyperalgesia

ESP2
Start date: May 2013
Phase: N/A
Study type: Interventional

Twenty percent of Americans suffer from chronic pain. Sleep disturbance is similarly prevalent and among the most common and disabling neurobehavioral problems associated with chronic pain. This research is designed to evaluate the effects of disrupted sleep patterns on mood, inflammation, the perception of pain, and pain relief. This study will help researchers understand the relationship between sleep and pain, and how sleep disturbance might influence chronic pain conditions.

NCT ID: NCT01791296 Completed - Delirium Clinical Trials

Does Nightly Dexmedetomidine Improve Sleep and Reduce Delirium in ICU Patients?

SKY-DEX
Start date: January 2011
Phase: Phase 4
Study type: Interventional

Specific Aims 1. Establish the feasibility of larger trial by implementing a sleep protocol in the ICU at 2 different sites. Specifically will be estimating the recruitment rates of patients and the compliance with both interventions. 2. Measure the safety and tolerance of adding night-time sedation with dexmedetomidine using adverse effects and withdrawal rates as indicators. 3. Measure the effect of nocturnal dexmedetomidine on pertinent clinical outcomes and use this outcome data to plan a larger, multicenter trial in this area. The goal of this study is to determine whether a night-time protocol that incorporates a pharmacologic intervention associated with improved sleep (i.e. dexmedetomidine) will improve sleep quality and reduce the incidence of delirium and sub-syndromal delirium in critically ill patients.

NCT ID: NCT01786564 Completed - Diabetes Clinical Trials

Home Sleep and Circadian Phase: Mediators of Diabetes Risk

Start date: December 6, 2011
Phase:
Study type: Observational

The purpose of this study is to determine if deficient sleep and/or disruption with the body's internal clock ("circadian rhythms") are associated with diabetes risk. This study is being done to look at the possible relationships between sleep and risk of diabetes by examining sleep in the home and diabetes risk in the laboratory.